{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:36:50Z","timestamp":1790087810231,"version":"4.0.1"},"reference-count":38,"publisher":"Korean Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["e-dmj.org"],"crossmark-restriction":true},"short-container-title":["Diabetes Metab J"],"published-print":{"date-parts":[[2024,11,30]]},"abstract":"<jats:p>Background: This study aimed to provide updated insights into the incidence and management of cardiovascular disease (CVD) in Korean adults with diabetes.Methods: Using data from the Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey, we analyzed the representative national estimates of CVD in adults with diabetes.Results: The age- and sex-standardized incidence rate of ischemic heart disease (IHD), ischemic stroke, and peripheral artery disease (PAD) decreased from 2010 to 2019 in individuals with type 2 diabetes mellitus (T2DM). However, an increase in the incidence of heart failure (HF) was observed during the same period. Only 4.96% of adults with diabetes and CVD achieved optimal control of all three risk factors (glycemic levels, blood pressure, and lipid control). Additionally, high-intensity statin treatment rates were 8.84% and 9.15% in individuals with IHD and ischemic stroke, respectively. Treatment with a sodium-glucose cotransporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1RA) was relatively low in 2019, with only 11.87%, 7.10%, and 11.05% of individuals with IHD, ischemic stroke, and HF, respectively, receiving SGLT2i treatment. Furthermore, only 1.08%, 0.79%, and 1.06% of patients with IHD, ischemic stroke, and HF, respectively, were treated with GLP-1RA.Conclusion: The incidence of most CVD (IHD, ischemic stroke, and PAD) decreased between 2010 and 2019, whereas the incidence of HF increased. The overall use of high-intensity statins, SGLT2i, and GLP-1RA remained low among individuals with T2DM and CVD.<\/jats:p>","DOI":"10.4093\/dmj.2024.0275","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T02:14:04Z","timestamp":1732241644000},"page":"1084-1092","update-policy":"https:\/\/doi.org\/10.4093\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular Disease &amp;amp; Diabetes Statistics in Korea: Nationwide Data 2010 to 2019"],"prefix":"10.4093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2703-7033","authenticated-orcid":true,"given":"Jin Hwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-0408","authenticated-orcid":true,"given":"Jae-Taek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-4572","authenticated-orcid":true,"given":"Hyuk-Sang","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on Behalf of the Diabetic Vascular Disease Research Group of the Korean Diabetes Association","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2567","reference":[{"key":"ref1","first-page":"2019","volume-title":"The lancet commission on diabetes: using data to transform diabetes care and patient lives","author":"Chan","year":"2021"},{"key":"ref2","first-page":"S179","volume-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2024","year":"2024"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0106"},{"key":"ref5","first-page":"1","volume-title":"Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013)","author":"Jung","year":"2017"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0175"},{"key":"ref7","first-page":"575","volume-title":"2023 Clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association","author":"Choi","year":"2023"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0160"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv319"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2021025"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.1.32"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1608664"},{"key":"ref13","volume-title":""},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01039-y"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10578"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2196\/34908"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2015.89.6.319"},{"key":"ref18","volume-title":"2022 Korean Heart Failure Fact Sheet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2004967"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2024816"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1611925"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1811744"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2204233"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1812389"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1504720"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1607141"},{"key":"ref27","first-page":"121","volume-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","author":"Gerstein","year":"2019"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1603827"},{"key":"ref29","first-page":"S140","volume-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023","author":"ElSayed","year":"2023"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0137"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-s009"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2023.0225"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.48030"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2926"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.121.021084"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00706-4"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0209"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0172"}],"container-title":["Diabetes &amp; Metabolism Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-dmj.org\/upload\/pdf\/dmj-2024-0275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-dmj.org\/journal\/view.php?doi=10.4093\/dmj.2024.0275","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-dmj.org\/upload\/pdf\/dmj-2024-0275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:04:18Z","timestamp":1736121858000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-dmj.org\/journal\/view.php?doi=10.4093\/dmj.2024.0275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.4093\/dmj.2024.0275","relation":{},"ISSN":["2233-6079","2233-6087"],"issn-type":[{"value":"2233-6079","type":"print"},{"value":"2233-6087","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"2024-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-30","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}